These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 5298999)

  • 41. [Therapeutic results of the otorhinolaryngological infections with clindamycin-2-palmitate (author's transl)].
    Sanbe B; Murakami H; Jo K
    Jpn J Antibiot; 1973 Dec; 26(6):540-4. PubMed ID: 4544499
    [No Abstract]   [Full Text] [Related]  

  • 42. [Isoxazolylpenicillins. What conclusions can be drawn from their serum concentration].
    Melby K
    Tidsskr Nor Laegeforen; 1976 Nov; 92(33):1749-50. PubMed ID: 996841
    [No Abstract]   [Full Text] [Related]  

  • 43. [Clinical uses of Dicloxacillin (Staphcillin-A)--staphylococcal sensitivity and clinical effects].
    Tachibana K; Yamada M; Takeda T; Ogawa Y
    Hifuka Kiyo; 1966 Nov; 61(4):334-6. PubMed ID: 6009649
    [No Abstract]   [Full Text] [Related]  

  • 44. [Tweenal, a new aerosol with antigenic power. Its use in 120 patients].
    Spilzinger LA
    Minerva Med; 1972 Oct; 63(70):3825-30. PubMed ID: 5079123
    [No Abstract]   [Full Text] [Related]  

  • 45. [Clinical study on amoxicillin in otorhinolaryngological field (author's transl)].
    Hommura Y; Sakamoto Y; Matsukawa J; Shinkawa A
    Jpn J Antibiot; 1975 Jun; 28(3):353-62. PubMed ID: 1152288
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Shunt sepsis. On the clinical aspects of septic complications of intermittent hemodialysis].
    Stille W; Brass H; Hach W; Renner D; Heintz R
    Dtsch Med Wochenschr; 1967 Mar; 92(11):467-72. PubMed ID: 6019682
    [No Abstract]   [Full Text] [Related]  

  • 47. [Basic and clinical studies on cefsulodin for the otorhinolaryngological infections].
    Furuta S; Fukuda K; Ohhori Y; Ogawa K; Iida F; Ohyama M
    Jpn J Antibiot; 1982 Dec; 35(12):2844-50. PubMed ID: 7182540
    [No Abstract]   [Full Text] [Related]  

  • 48. Effect of dicloxacillin, oxacillin, and nafcillin upon staphylococcal population and rate of healing of soft-tissue lesions.
    Hartman RE; Carleton J; Lustberg A; Hamburger M
    Antimicrob Agents Chemother (Bethesda); 1966; 6():64-8. PubMed ID: 5985303
    [No Abstract]   [Full Text] [Related]  

  • 49. [Clinical application of clindamycin-2-phosphate to otorhinolaryngological infections (author's transl)].
    Baba S; Wada K; Naito M; Hondo J; Fukuoka Y
    Jpn J Antibiot; 1977 May; 30(5):341-5. PubMed ID: 266632
    [No Abstract]   [Full Text] [Related]  

  • 50. [Clinical trials of rifampicin in otorhinolaryngological pathology].
    Borasi G
    Arch Maragliano Patol Clin; 1969; 25(5):385-9. PubMed ID: 5262666
    [No Abstract]   [Full Text] [Related]  

  • 51. Midecamycin in the treatment of otorhinolaryngological infections.
    Polpathapee S; Na-Nakorn A
    J Med Assoc Thai; 1985 Aug; 68(8):412-4. PubMed ID: 4067459
    [No Abstract]   [Full Text] [Related]  

  • 52. [Evaluation of ampicillin-dicloxacillin combination (HI-56 G) in pediatric field (author's transl)].
    Nakazawa S; Sato H; Chikaoka H; Kanda S
    Jpn J Antibiot; 1980 Nov; 33(11):1232-6. PubMed ID: 6909315
    [No Abstract]   [Full Text] [Related]  

  • 53. [Fundamental studies on synthetic cephalosporin antibiotics. 2. Therapeutic effects of oral administration on experimental infections in mice and their distribution in the body].
    Nakazawa S; Tsuji A; Watanaba Y; Tsujimoto S
    J Antibiot B; 1967 Aug; 20(4):254-8. PubMed ID: 4866093
    [No Abstract]   [Full Text] [Related]  

  • 54. [Double-blind study of the association of sulfamethoxazole and trimethoprim in otorhinolaryngological infections].
    Mesure R
    Acta Otorhinolaryngol Belg; 1973; 27(1):27-33. PubMed ID: 4697134
    [No Abstract]   [Full Text] [Related]  

  • 55. [Semisynthetic penicillins and their evaluation in the pulmonological clinic].
    Zamotaev IP; Sokolova VI; Navashin SN; Kuznetsova SM; Averina RI
    Ter Arkh; 1977; 49(10):69-73. PubMed ID: 594900
    [No Abstract]   [Full Text] [Related]  

  • 56. Otorhinolaryngological evaluation of Phlogosam foam-spray.
    Zelen B
    Ther Hung; 1988; 36(3):136-9. PubMed ID: 3250002
    [No Abstract]   [Full Text] [Related]  

  • 57. Use of ceftazidime in the treatment of otorhinolaryngoiatric bacterial infections.
    Vellucci A; Marcucci L; Greco D; Schinaia N; Caterini A; Benedetti M
    Int J Clin Pharmacol Ther Toxicol; 1987 May; 25(5):282-8. PubMed ID: 3298082
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Clinical effect of a cephalosporin derivative, cefotiam, on otorhinolaryngologic infections].
    Baba S; Wada K; Hatano T; Kinoshita H; Sugimori H; Sasaki T; Miyano K; Maruyama H; Takimoto I; Inafuku S
    Jpn J Antibiot; 1983 Oct; 36(10):2693-710. PubMed ID: 6325739
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [The clinical efficacy of cefsulodin to the infection of otorhinolaryngological field].
    Baba S; Maruo T; Sasaki T; Miyano K; Maruyama H; Miyake H; Sakai M; Fujii K; Saito N; Takimoto I; Inafuku S; Nomura T; Yamashita K; Sato K; Ogawa A; Ueda T; Yoshizumi T; Nakai Y; Sugiyama M; Ohashi Y; Goto K; Ohta F; Murata K; Boku S; Miyamae M; Yonei K; Harada Y; Yajin K; Chikuie D; Hirata K
    Jpn J Antibiot; 1982 Dec; 35(12):2851-60. PubMed ID: 6763636
    [No Abstract]   [Full Text] [Related]  

  • 60. [Basic and clinical evaluation on clindamycin palmitate in otorhinolaryngological field infection (author's transl)].
    Iwasawa T
    Jpn J Antibiot; 1973 Aug; 26(4):393-9. PubMed ID: 4542676
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.